Related Experiment Videos
Surface immunoglobulin light-chain expression by the "common" all cell line REH
Clinical Immunology and Immunopathology
|October 1, 1985
Summary
The REH cell line expresses surface lambda light chain, indicating a more differentiated B-cell lineage in acute lymphoblastic leukemia (ALL). This finding supports the B-cell origin of ALL and provides insights into leukemia cell differentiation.
Area of Science:
- Immunology
- Hematology
- Cell Biology
Background:
- Acute lymphoblastic leukemia (ALL) is a heterogeneous cancer of lymphoid progenitor cells.
- The B-cell lineage is a common origin for ALL, but the differentiation stage of leukemic cells can vary.
- The REH cell line has been used to study ALL, but its precise B-cell differentiation status requires further clarification.
Purpose of the Study:
- To investigate the B-cell lineage commitment of the REH cell line.
- To determine the expression of immunoglobulin light chains in the REH cell line.
- To assess the differentiation stage of REH cells within the B-cell lineage.
Main Methods:
- Flow cytometry was used to detect cytoplasmic and surface immunoglobulin expression.
- Nucleic acid blotting was employed to analyze immunoglobulin gene status (kappa and lambda).
- RNA analysis was performed to quantify mu and lambda chain messenger RNA (mRNA) levels, with and without TPA treatment.
Main Results:
- The REH cell line demonstrated cytoplasmic heavy chain and surface lambda light-chain expression.
- Nucleic acid blotting confirmed deletion of kappa genes and rearrangement of lambda genes.
- REH cells expressed mu and lambda RNA, with increased levels upon TPA treatment.
Conclusions:
- The presence of surface immunoglobulin lambda light chain in the REH cell line indicates a more advanced differentiation stage along the B-cell lineage than previously recognized.
- These findings provide further support for the B-cell origin of common ALL.
- The REH cell line serves as a valuable model for studying B-cell differentiation in leukemia.